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Summary
Objective: A major barrier inhibiting the discovery of structural modifying agents for osteoarthritis (OA) is an incomplete understanding of early
disease events. Herein, we investigated the time course of collagen II cleavage and ﬁbril disruption in the well-validated Hartley guinea pig
model of spontaneous OA of the knee.
Methods: Knee joints of 46 male Hartley guinea pigs were analyzed at 3 weeks, 2, 4, 7, 10, 12, and 18 months of age for histological severity
of OA, cartilage collagen ﬁbril disruption by semi-quantitative polarized light microscopy, and expression of type II collagen degradation bio-
markers, 9A4 and Coll2-1, by immunohistochemistry. In addition, serum biomarkers speciﬁc for collagen II degradation, CTX-II, C2C, and
Coll2-1 were quantiﬁed.
Results: Collagen ﬁbril disruption and expression of the collagenase-generated cleavage neoepitope, 9A4, were observed as early as 2
months of age, despite the appearance of histological OA at 4 months of age. Only serum Coll2-1 increased coincident with the early disrup-
tion of the collagen ﬁbril between 3 weeks and 7 months, in contrast to serum C2C, which did not change signiﬁcantly or correlate with his-
tological severity. Inversely, CTX-II declined dramatically from 3 weeks to 4 months and remaining low thereafter, coincident with growth plate
turnover.
Conclusions: Collagenase cleavage and disruption of the type II collagen network are early OA disease events in this model, preceding his-
tological evidence of proteoglycan loss. The markedly different serum proﬁles of collagen II-related biomarkers during the early stages of dis-
ease development suggest compartmental segregation and temporal regulation of collagen degrading enzymes.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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A greater focus on early, pre-radiographic osteoarthritis
(OA) is needed to provide insight into targets for interven-
tion at a stage more amenable to modiﬁcation. The early
events are difﬁcult to characterize in primary human OA
due to the great uncertainty surrounding disease onset
and the great biological variability in disease progression.
The Hartley guinea pig however provides a consistent
model of spontaneous and progressive degeneration of
the knee that closely resembles knee OA in humans1,2.
This animal model is especially attractive for studies of
OA pathology because it represents primary idiopathic
OA, and the guinea pig, unlike rodents, expresses both in-
terstitial collagenases-1 and -3 which are associated with
cartilage damage3, and OA in humans4. We hypothesized
that the Hartley guinea pig would provide a physiologically
relevant model in which to analyze early OA disease events
to gain insights into mediators of disease onset. This study
focused on characterizing the collagen II-related events*Address correspondence and reprint requests to: Virginia Byers
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397relative to histological OA and proteoglycan loss in the
course of disease development.
The collagen ﬁbril network maintains the volume, shape,
and tensile strength of the extracellular matrix of articular
cartilage. Type II collagen is relatively speciﬁc to articular
cartilage and is the most abundant cartilage protein, repre-
senting 15e25% of the wet weight, 50% of the dry weight5,
and >90% of the total collagen content6. Disruption of
this ﬁbrillar network is mediated by speciﬁc matrix metallo-
proteinase (MMP) enzymes that cleave collagen, namely
collagenases-1, -2 and -3 (MMPs-1, -8, and -13). Collage-
nase-mediated cleavage of type II collagen produces two
fragments: a 3/4 length fragment and a 1⁄4 length fragment.
Once this initial cleavage has taken place, the triple helical
collagen ﬁbril unwinds and becomes susceptible to degra-
dation by other enzymes such as gelatinases. The biologi-
cal half-life of type II collagen is estimated to be 117
years in human adult cartilage7, contributing to the concept
that collagen ﬁbril degradation is a key feature of OA
because the irreversible damage imposed on this matrix
molecule is not adequately compensated for by new protein
synthesis.
The proteolysis of type II collagen yields three types of
neoepitope fragments accessible to body ﬂuids8: the colla-
genase-generated C2C neoepitope on the carboxy end of
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epitope10 in the triple helical domain near the carboxy end
of the 3/4 fragment, and the matrix metalloprotease-gener-
ated neoepitope11,12 CTX-II13, localized to the mature car-
boxy end or telopeptide of the collagen molecule (Fig. 1).
We have found that all three types of collagen II neoepi-
topes are measurable in the guinea pig, providing a means
of quantifying the time course of collagen II metabolism in
this animal model. These provided adjunctive measures
with which to monitor the disease course to complement
the primary histological, and polarized light microscopic out-
comes of collagen degradation in this model system.MethodsANIMALSSix male Hartley guinea pigs were obtained from Charles River Laborato-
ries (Wilmington, MA) at 3 weeks of age, and an additional forty male Hartley
guinea pigs were obtained at 2 months of age and raised until sacriﬁce at 2
(n¼ 6), 4 (n¼ 6), 7 (n¼ 6), 10 (n¼ 6), 12 (n¼ 6), and 18 (n¼ 10) months of
age. The Institutional Animal Care and Use Committee approved all proce-
dures. Blood was collected into SST Vacutainer tubes (VWR International,
West Chester, PA) at each time point. The samples were centrifuged at
3000 rpm for 15 min and sera were aliquoted and frozen at 80 C until
analyzed. The right knee joint from each animal was ﬁxed for 24 h in 10%
buffered formalin, followed by decalciﬁcation in 10% ethylenediaminetetra-
acetic acid (EDTA) in 0.1 M phosphate buffer, pH 7.6e7.8. Parafﬁn sections
(5 mM) of the central region of the joint were stained with either toluidine blue
for histological analyses or picrosirius red and examined under polarized
light to evaluate collagen birefringence.HISTOLOGICAL GRADINGA semi-quantitative modiﬁed Mankin histological grading system de-
scribed previously14 was used to evaluate OA severity in each tibial plateau
and femoral condyle. This scoring scheme permits site-speciﬁc and separate
scoring of cartilage structure (extent and severity of surface irregularities in-
cluding ﬁbrillation and clefts [0e8]), and proteoglycan content (as determined
by extent of toluidine blue staining [0e6]) and has demonstrated a correlation
with severity of OA as reﬂected by the synovial ﬂuid biomarkers, cartilage
oligomeric matrix protein (COMP) and keratan sulfate (KS)14e16. Histological
sections were graded by two observers (JLH, VBK) blinded to the animal
status.POLARIZED LIGHT MICROSCOPIC ANALYSESSlides containing histological sections for analyses of collagen network
orientation were exhaustively deparafﬁnized, as parafﬁn is strongly birefrin-
gent. Sections were hydrated as described previously17 and treated at
37 C for 18 h in 2.0 mg bovine testicular hyaluronidase in 1.0 ml 0.1 M phos-
phate buffer at pH 6.0 to remove chondroitin sulfate molecules18, to eliminate
possible masking of collagen’s cationic binding sites for the polyanionicCTXII
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Fig. 1. Schematic representation of the speciﬁc type II collagen epi-
topes measured. The epitopes measured in sera result from the
three types of collagen degradation: collagenase cleavage (C2C),
denaturation (Coll2-1), and MMP-generated collagen telopeptides
(CTX-II).Sirius red molecules19. Sections were then stained for 30 min in 0.1% Sirius
red F3B (Polysciences, USA) dissolved in saturated picric acid, which
enhances the normal birefringency of collagen ﬁbers in tissue sections20,
and then washed, dehydrated, and mounted with cover slips. Sections
were analyzed with a Nikon microscope equipped with polarizing ﬁlters
and the induced birefringence was determined by turning the analyzer in
two opposite directions. The optical properties of the extracellular matrix,
namely the presence or absence of birefringence, indicated the orientation
of the collagen ﬁbers20,21 of the articular cartilage. The relative loss of colla-
gen birefringence (expressed as a percentage) was based on a comparison
with the pattern of birefringence in the 3-week old guinea pig knee cartilage
which was taken to represent normal (100%) birefringence. These assess-
ments were made blinded to animal age and histological score. The images
were obtained using Metamorph Software 4.01. The entire area of articular
cartilage was circumscribed to obtain a total area. Likewise, areas of normal
vs altered birefringence were circumscribed allowing expression of birefrin-
gence results as percentages of total cartilage area.IMMUNOHISTOCHEMISTRYSections of guinea pig knees were stained with monoclonal antibody
(mAb) 9A4 (kindly provided by Dr. Peter Mitchell) and antisera D3 containing
antibodies to Coll2-1. The 9A4 mAb recognizes the collagenase-generated
neoepitope at the C-terminus of the collagen 3/4 fragment22 and was readily
available whereas the anti-C2C antibody was not commercially available and
has been reported to be unsuitable for immunohistochemistry23. The antise-
rum to Coll2-1 recognizes a denaturation epitope of collagen II that results
from unwinding and thus detects only degraded collagen, ether in situ (in car-
tilage) or in body ﬂuids24. Parafﬁn-embedded sections were deparafﬁnized
with xylene and then rehydrated with graded ethanol. Endogenous peroxi-
dase activity was blocked by incubation of the sections with freshly prepared
0.5% (vol/vol) H2O2 in absolute ethanol for 10 min at room temperature. To
enhance the permeability of the extracellular matrix, glycosaminoglycans
were removed by incubating the sections with 0.4 U/l proteinase-free chon-
droitinase ABC (Sigma) in 0.1 M TriseHCl pH 8.0 for 30 min at 37 C.
Non-speciﬁc binding was blocked by incubation of the sections with 100 ml
of 1% normal goat serum (Jackson ImmunoResearch) diluted in tris buffered
saline (TBS); 50 mM Tris, 138 mM NaCl pH 7.6 for 30 min. For staining with
mAb 9A4, sections were incubated overnight at 4 C with 15 mg/ml of mAb
9A4 according to previously described methods3. Staining for Coll2-1 was
performed by incubating sections for 2 h with 100 ml of antisera derived
from rabbits (D3) diluted 1/100 in TBS containing 1% normal goat serum,
as described previously23. As a negative control, sections were treated
with goat non-immune serum diluted 1/100 as the substitute for the primary
antibody.COLLAGEN II BIOMARKER ANALYSESLevels of serum C2C were quantiﬁed by a commercially available
enzyme-linked immunosorbent assay (ELISA) (IBEX, Montreal, Quebec) in
serum diluted 1:2, as per the manufacturers’ protocol. The intra- and inter-
assay variability for C2C was 3.3% and 16.3% respectively, as reported
previously16. The denaturation epitope, Coll2-1 and the nitrosylated epitope,
Coll2-1NO2, localized to the helical domain of type II collagen
24,25 were
quantiﬁed in guinea pig sera (diluted 8-fold) by competitive ELISA in dupli-
cate with polyclonal rabbit antisera (D3 and D37, respectively)24. For
Coll2-1, the intra-assay and inter-assay variability were 8.2% and 9.3%
respectively. Levels of serum CTX-II were quantiﬁed using the serum Pre-
clinical Cartilaps ELISA (Nordic Bioscience), an assay designed to detect
degradation products of C-terminal telopeptides of type II collagen in animal
sera. The intra-assay and inter-assay variability were 5.1% and 8.9% respec-
tively. Biomarker assays were performed blinded to guinea pig age or histo-
logical data. Results were expressed as mean þ standard deviation (SD).STATISTICAL ANALYSESAll statistical analyses were performed using Prism GraphPad 5.0 (Graph-
Pad Software, La Jolla, CA). The individual components of the histological
scores (cartilage structure and proteoglycan content) and the birefringence
of the four joint surfaces [medial and lateral femoral (LF) condyles, medial
and lateral tibial (LT) plateaus] at the various ages were analyzed by the
one-way analysis of variance (ANOVA), non-parametric KruskaleWallis test,
followed by Dunn’s Multiple Comparison post-hoc test; the non-parametric
ManneWhitney testwasused to compare thedifferences in histological scores
and measures of birefringence between either medial or lateral compartments
or tibial and femoral surfaces, as well as the levels of Coll2-1 at 3 weeks and 4
months of age. To evaluate for potential correlation of the biomarkers,
non-parametric Spearman correlationswere calculated. In addition, total histo-
logical scores were separated into quartiles and corresponding levels of bio-
markers were analyzed by one-way ANOVA, non-parametric KruskaleWallis
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ered statistically signiﬁcant at P< 0.05.ResultsHISTOLOGICAL SCORING AND COLLAGEN BIREFRINGENCEHistological changes in cartilage structure and/or proteo-
glycan content consistent with histological knee OA were
apparent by 4 months of age at all four surfaces of the
knee. The greatest severity of both cartilage structural dam-
age and loss of proteoglycan was evident for the medial tib-
ial (MT) surface of the knee and worsened throughout the
course of disease development, with the most pronounced
change in histological scores occurring between 4 and 7
months of age (Fig. 2). Signiﬁcant differences in cartilage
structure scores were observed between medial and lateral
compartments (7 month P¼ 0.05; 10 month P¼ 0.02; 12
month P¼ 0.03; 18 month P¼ 0.0002) as well as between
tibial and femoral surfaces at time points from 7 to 18
months of age (7 month P¼ 0.05; 10 month P¼ 0.10; 12
month P¼ 0.01; 18 month P¼ 0.03). In contrast, differ-
ences in proteoglycan scores were only signiﬁcant between
tibial and femoral surfaces at time points from 7 to 12
months of age (7 month P¼ 0.002; 10 month P¼ 0.01; 12
month P¼ 0.09; 18 month P¼ 0.005). Comparing the me-
dial and lateral compartments, there were no signiﬁcant dif-
ferences in proteoglycan content scores with the exception
of the 18 month time point (18 month P¼ 0.04).
The tibial surface at 3 weeks of age showed a typical pat-
tern of birefringence: normal birefringence on the surface
zone, no birefringence in the middle zone, and normal bire-
fringence in the deep zone. Representative sections of 2, 4,
7, 10 and 12-month-old guinea pig knee joints, depicting
examples of altered cartilage birefringence, are shown in
Fig. 3. Beginning at 2 months of age, the normal pattern
of birefringence was diminished by a mean 14% followed0
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Fig. 2. Histological damage of the guinea pig knee joints by compartment.
in each of the compartments (LF; LT; MF and MT) of the guinea pig knee
time at various sites within the joint were calculated by the one-way ANOV
ered signiﬁby a progressive loss of normal collagen birefringence of
all four surfaces with age (Fig. 4). Overall, the birefringent
area of cartilage declined a mean 50% from 3 weeks to
12 months of age. From 4 months onward, reductions in
normal birefringence were signiﬁcantly greater on the tibial
side of the joint compared with the corresponding femoral
surface. However, the extent of the loss of birefringence
was not signiﬁcantly different between the medial and lat-
eral compartments of the tibial plateau at any time point.IMMUNOHISTOCHEMICAL STAININGImmunostaining with the 9A4 mAb was performed to
evaluate the time course of collagenase activity manifested
as the appearance of the 3/4 collagen cleavage neoepitope.
Collagen cleavage by collagenase preceded histological
OA, with readily apparent 9A4 immunostaining at 2 months
of age in the MT compartment (Fig. 5), compared to the uni-
form staining of the remainder of the full thickness articular
cartilage in the LT compartment. The manifestation of colla-
gen cleavage by collagenase (9A4 staining) detected in
both the medial and LT compartments of the knee at 2
months of age corresponded to temporal alterations in bire-
fringence and also preceded histological OA. Throughout
the time course, the pattern of 9A4 immunostaining in the
lateral compartment was positive and comparable to the
2-month old section; however, the pattern of 9A4 staining
of the MT compartment varied in conjunction with the devel-
opment of histological changes of OA. Compared to the pat-
tern and intensity of 9A4 immunostaining at 2 months of
age, at 4-months of age the MT compartment revealed
more intense staining of the extracellular matrix as well as
more pericellular staining of the chondrocytes in the middle
zone. The staining in the 7-month-old sections was more in-
tense than in the 4-month-old sections, speciﬁcally at the le-
sions sites, and there were many clusters of chondrocytesonths)
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(A) Mean cartilage structure scores and (B) mean proteoglycan loss
from 2 to 18 months of age. Differences in histological scores over
A non-parametric KruskaleWallis test. P values< 0.05 are consid-
cant.
Fig. 3. Representative coronal sections of whole joints depicting variations in percent areas of normal birefringence in the tibial compartment.
Appearance of the tibial surface at 3 weeks (A) showing a typical pattern of birefringence; normal birefringence on the surface (zone 1; red
arrowheads), no birefringence in zone 2 (red asterisks) and normal birefringence in zone 3; at 2 months of age (B) there is normal birefrin-
gence on the surface (zone 1; red arrowheads), no birefringence in zone 2 (red asterisks) with some reduction of normal birefringence in
zone 3; at 4 months of age (C) there is a loss of normal birefringence on the surface (zone 1), no birefringence in zone 2 and a mixture of
normal birefringence (dashed circle) and loss of normal birefringence is noted in zone 3; at 7 months of age (D) there is loss of normal bire-
fringence on the surface (zone 1), surface disruption (red asterisk), no birefringence in zone 2, and loss of normal birefringence is noted in
zone 3; at 10 months of age (E) there is loss of normal birefringence on the surface (zone 1) and evidence of surface disruptions (red aster-
isks), no birefringence in zone 2, and a mixture of normal birefringence (dashed circle) and loss of birefringence is noted in zone 3; at 12
months of age (F) there is a complete loss of normal birefringence on the surface (zone 1) followed by birefringence in zone 2 (dashed circle)
and again a mixture of normal (white dashed circle) and a loss of normal birefringence in zone 3. The solid white line approximates the car-
tilage bone interface. Original magniﬁcation 40x.
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Fig. 4. Disruption of the collagen network integrity with age. Collagen birefringence was scored semi-quantitatively from picrosirius red stained
sections of Hartley knee joints, aged 2 months to 18 months. The % loss of normal birefringence was estimated based upon comparison with
normal birefringence as seen in a reference area. Percentage loss of birefringence for each of the four compartments is shown (LF: ; LT: ;
MF: and MT: ).
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Fig. 5. Immunohistochemical expression of collagenase-generated collagen degradation. Immunostaining of representative guinea pig knee
sections with monoclonal antibody (mAb) 9A4. The MT compartment (A) of a 2-month-old guinea pig depicts cleavage by collagenase in the
superﬁcial zone of the compartment which preceded histological changes associated with OA. In contrast, there is more uniform extracellular
staining throughout the articular cartilage of the LT compartment at 2 months of age (B). MT compartment of 4 month old (C) and 7 month old
(E) stained with monoclonal antibody 9A4 show more intense staining of the superﬁcial zone and areas of cartilage degradation, respectively.
Arrows indicate the pericellular staining of chondrocytes throughout the middle and deep zones of the articular cartilage. MT compartment of
a 2-month-old guinea pig knee stained with secondary antibody only (negative control) (D). Extracellular staining of the epiphyseal plate was
evident (F). Magniﬁcation bars: (AeE; 40¼ 50 mM and F; 10¼ 100 mM).
401Osteoarthritis and Cartilage Vol. 18, No. 3in the middle zone across the entire compartment that had
deﬁnite pericellular staining. Extracellular staining of the
epiphyseal plate was observed.
Tissue expression of Coll2-1 was quite different than that
of 9A4. Instead of the predominant extracellular staining of
the full thickness articular cartilage, staining of sections with
polyclonal antisera to Coll2-1 (Fig. 6) revealed speciﬁc
staining primarily in the chondrocytes of the superﬁcial
zone of 2-month-old guinea pig knee sections with some
additional staining in the chondrocytes of the middle and
deep zones of the articular cartilage and no staining of
the extracellular matrix. In the 4-month-old sections, the
superﬁcial zone was devoid of chondrocytes however,
staining was observed in the chondrocytes of the middleand deep zones. By 7 months of age, there was faint stain-
ing present at the surface of the articular cartilage in the
areas of cartilage ﬁbrillation and ﬁssures, however, the su-
perﬁcial zone was devoid of chondrocytes, and there was
less staining of the chondrocytes in the middle and deep
zones, compared to that observed in the 4-month-old sec-
tions. Interestingly, there was no intra- or extracellular stain-
ing of Coll2-1 in the growth plate.TYPE II COLLAGEN BIOMARKERSWe compared serum levels of three type II collagen bio-
markers, representing three types of neoepitopes created
during collagen ﬁbril degradation (Fig. 7). Mean serum
Fig. 6. Immunohistochemical expression of Coll2-1 in guinea pig knee sections. The MT (A) and LT (B) compartments of a 2-month-old guinea
pig demonstrates the presence of the Coll2-1 epitope intracellularly in chondrocytes of the superﬁcial, middle, and deep zones, but no extra-
cellular staining of the cartilage matrix. MT compartment of a 4 month old (C) guinea pig shows no staining in the superﬁcial zone devoid of
chondrocytes, however in contrast, arrows indicate the staining of the ﬁbrillated cartilage in the 7-month-old section (E). Arrows indicate the
intracellular staining of chondrocytes throughout the deep zone of the articular cartilage. MT compartment of a 2-month-old guinea pig knee
stained with secondary antibody only (negative control) (D). No extracellular staining of the epiphyseal plate was evident (F). Magniﬁcation
bars: (AeE; 40¼ 50 mM and F; 10¼ 100 mM).
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from 3 weeks to 4 months of age (P¼ 0.002), and remained
consistently elevated thereafter to 18 months of age. Levels
of Coll2-1NO2, the nitrosylated version of Coll2-1, were
measured in the same samples and concentrations equaled
1e2% of the serum concentrations of Coll2-1 throughout
the time course. The serum proﬁle for Coll2-1NO2 was sim-
ilar to that of Coll2-1 and the two measures were highly cor-
related (r¼ 0.9441, P< 0.0001) (data not shown). Serum
C2C decreased slightly from 3 weeks to 2 months of age,
but there was no variation in mean C2C concentrations
coincident with the development of histological OA. At 3
weeks of age, mean serum CTX-II was at its highest and
rapidly declined to barely detectable levels by 7 months of
age, showing very little change from 7 to 18 months ofage. Correlations of the biomarkers were explored to as-
sess the possibility that these serum biomarkers are reﬂec-
tive of inter-related biological processes. There was
a signiﬁcant positive correlation between Coll2-1 and C2C
(r¼ 0.3788, P¼ 0.009). There was a signiﬁcant negative
correlation between CTX-II and Coll2-1 (r¼0.4076,
P¼ 0.005). There was no signiﬁcant correlation between
CTX-II and C2C (r¼0.1710, P¼ 0.2613).
The total histological scores were divided into quartiles
(Q) with the following ranges of scores (Q1: 0e0; Q2:
0e9; Q3: 10e18; Q4: 19e32). Mean levels of serum
Coll2-1 increased signiﬁcantly between Q1 and Q2 histol-
ogy score (P< 0.01) and mean levels remained elevated
and unchanged for the higher severity quartiles; Q1eQ3
(P< 0.05), Q1eQ4 (P< 0.001) (Fig. 8). There were no
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403Osteoarthritis and Cartilage Vol. 18, No. 3signiﬁcant differences in levels of serum C2C with onset
and progression of histological OA. Levels of serum CTX-
II were elevated in Q1 (young animals with no histological
OA), and decreased signiﬁcantly (ANOVA P¼ 0.0001) for
higher severity quartiles, representing increasing severity
of histological OA.Discussion
In the present study, we observed reductions in normal
collagen network birefringence beginning at 2 months of
age, prior to evidence of histological OA and provide
semi-quantitative characterization of the temporal course
of this collagen ﬁbril disruption. We conclude that articular
collagen ﬁbril disruption is an early OA-related event in
this model system. Other means of analysis, namely mag-
netic resonance imaging (MRI), also point to this conclu-
sion; MRI has provided evidence for cartilage swelling
between 2 and 6 months of age in the Hartley guinea pig
knee26. In studies of human tissue, swelling has been con-
vincingly attributed to disruption of collagen27, enabling the
proteoglycan to absorb water. This provides further evi-
dence in support of early collagen ﬁbril disruption in this
model system.
Several other studies have demonstrated alterations in
collagen ﬁbril integrity prior to disruption in the articular**
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Fig. 8. Distribution of serum biomarker levels by quartiles of total histolog
0e0; Q2: 0e9; Q3: 10e18; Q4: 19e32) to examine the distribution of le
**P< 0.01, ***Psurface (one canine study28, one rabbit study19, and one
guinea pig study17). In the guinea pig study, Han et al. ob-
served a loss of normal birefringence of the articular carti-
lage in the knee and ankle joints with age and reported
greater reductions on the tibial side of the joint compared
with the corresponding femoral surface17.
Previously, we demonstrated the presence of collage-
nase 1 and collagenase 3 in the extracellular matrix of Hart-
ley guinea pigs as early as 2 months of age3. In this study,
we have conﬁrmed the expression of collagenase activity in
sections as early as 2 months of age in both the medial and
lateral compartments of the knee, prior to histological evi-
dence of OA but coincident with collagen ﬁbril disruption
by birefringence. Although, the collagen abnormalities are
widespread, the histological abnormalities of cartilage struc-
ture and proteoglycan content are differentially located in
the medial compartment. Thus, it would appear that colla-
gen cleavage and network disorganization is a necessary,
but not sufﬁcient cause for the histological manifestation
of disease. It is likely that the greater mechanical load on
the medial compartment, in conjunction with obesity, for
which the guinea pig is well known, combine to accelerate
the disease in the medial compartment in the face of colla-
gen ﬁbril disruption. The equivalent loss of birefringence in
both medial and lateral compartments could reﬂect the
overall metabolically active bone and cartilage which has
been reported previously in the Hartley strain of guinea
pig14 and may provide an explanation for the prevalence
of OA in this strain.
Both Coll2-1 and C2C displayed inverse serum proﬁles to
that of serum CTX-II. The CTX-II epitope can result from the
degradation of type II collagen in a single joint, as measured
in synovial ﬂuid29, or may be reﬂective of degradation of
type II collagen in mineralized tissue30. Serum levels of
CTX-II reﬂected a pattern most compatible with collagen II
turnover in the growth plate cartilage, being highest at 3
weeks of age and then rapidly declining by 4 months and
barely detectable by 7 months of age onward. The growth
plates in the guinea pig long bones do not ossify until
18e24 months, but bone growth, and by inference growth
plate turnover, ceases at 4 months of age31, and is barely
measurable during the period of histological OA develop-
ment in this model system.
Coll2-1 has been shown to be signiﬁcantly elevated in OA
patients compared to controls24. Levels of serum and
urinary Coll2-1 have been shown to predict progression of
radiographic knee joint space narrowing over 1 year inC
3 4
sCTXII
1 2 3 4
0
50
100
150
200
250
300
350
400
450
500
550
600
650
 Quartiles
s
C
T
X
I
I
(
p
g
/m
l
)
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vels of serum biomarker by severity of histological OA. *P< 0.05,
< 0.001.
404 J. L. Huebner et al.: Collagen ﬁbril disruption occurs early in primary guinea pig knee OAhumans24,32, and to decline signiﬁcantly following knee or
hip joint replacement providing evidence for a joint speciﬁc
origin of this marker33. The results in this study suggest that
the Coll2-1 biomarker may be an early indicator of the onset
of chondropathy in the guinea pig and an indicator of ongo-
ing disease activity during the period of disease progres-
sion. Based on these results, we would categorize Coll2-1
as a burden of disease activity marker according to the no-
menclature proposed by Bauer et al.34. It is both remarkable
and fortuitous that growth plate collagen II turnover is not re-
ﬂected in the serum levels of Coll2-1. In addition, the Coll2-1
epitope, in contrast to the 9A4 epitope, was not observed in
the growth plate itself. The reason for this is unknown; how-
ever, it suggests that this marker may be more indicative of
pathological articular cartilage type II collagen turnover. We
speculate that the enzymes responsible for growth plate
collagen turnover are different from those of pathological ar-
ticular cartilage turnover and lead to different end biomarker
products12.
We were limited in this study by our inability to quantify
levels of collagen biomarkers in synovial ﬂuid, a site more
proximal to the events under study. A previous report of
CTX-II measurements in the synovial ﬂuid of the rat re-
quired a larger volume than was available from our study.
We also did not measure speciﬁc markers of proteoglycan
turnover, as they were not available for this animal model.
Such a biomarker may have provided a more sensitive
measure of disease onset than was provided by histological
evidence of proteoglycan loss.
Another limitation of this study was the lack of control an-
imals which would have allowed for distinctions to be made
between age-related and pathological changes in this
model. However, our previous work, using Strain 13 guinea
pigs as age-matched controls to the Hartley guinea pigs,
demonstrated signiﬁcant differences in cartilage and bone
metabolism as well as susceptibility to OA, distinguishing
the OA process from an age-related phenomenon14. These
ﬁndings were later conﬁrmed by subsequent studies using
other strains of guinea pig as age-matched controls16,35e39.
Together, these studies support the hypothesis that
changes occurring in the Hartley strain guinea pig are not
likely to be simply due strictly to age, but more speciﬁcally
to pathological alterations in cartilage, bone, metabolism,
ligaments, and biomarkers that make this strain more sus-
ceptible to the development of OA.
In summary, disruption of the collagen network integrity
appears to be a very early event in the cascade of joint de-
generative processes in the Hartley guinea pig model of
knee OA, as evidenced by the time course of the loss of bi-
refringence, creation of neoepitopes speciﬁc to cleavage by
collagenases, and serum type II collagen biomarkers. We
speculate that disruption of the collagen network predis-
poses to OA and, in conjunction with excess mechanical
load localized to the medial compartment and exacerbated
by obesity, leads preferentially to progression of histological
OA in the MT compartment.Conﬂict of interest
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